LOGIN
Collagen/thrombin and autologous platelet hemostatic agent reduces transfusion during TKA
May 2013
Collagen/thrombin and autologous platelet hemostatic agent reduces transfusion during TKA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Prospective randomized evaluation of a collagen/thrombin and autologous platelet hemostatic agent during total knee arthroplasty
J Arthroplasty. 2012 May;27(5):695-702. Epub 2011 Oct 27Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
100 patients undergoing primary total knee arthroplasty were randomised to receive either standard haemostasis and Vitagel, a haemostatic treatment, or a control group receiving standard haemostasis alone to examine the effects on blood transfusions. No patients in the Vitagel group required blood transfusions compared with 10% of the patients in the control group. Patients in the Vitagel group al...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.